Neogen Corp (NEOG): Net Income
-$7.90M
Year ended 2026-05-31
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2026-05-31 | -$7.90M | n/m | 2026-07-30, From 2025-06-01 |
| 2025-05-31 | -$1.09B | n/m | 2026-07-30, From 2024-06-01 |
| 2024-05-31 | -$9.40M | n/m | 2026-07-30, From 2023-06-01 |
| 2023-05-31 | -$22.87M | n/m | 2025-07-30, From 2022-06-01 |
| 2022-05-31 | $48.31M | -20.7% | 2024-07-30, From 2021-06-01 |
| 2021-05-31 | $60.88M | +2.4% | 2023-08-15, From 2020-06-01 |
| 2020-05-31 | $59.48M | -1.2% | 2022-07-27, From 2019-06-01 |
| 2019-05-31 | $60.18M | -4.7% | 2021-07-30, From 2018-06-01 |
| 2018-05-31 | $63.15M | +44.2% | 2020-07-30, From 2017-06-01 |
| 2017-05-31 | $43.79M | +19.8% | 2019-07-30, From 2016-06-01 |
| 2016-05-31 | $36.56M | +9.1% | 2018-07-27, From 2015-06-01 |
| 2015-05-31 | $33.53M | +19.1% | 2017-07-28, From 2014-06-01 |
| 2014-05-31 | $28.16M | +3.6% | 2016-07-29, From 2013-06-01 |
| 2013-05-31 | $27.19M | +20.8% | 2015-07-30, From 2012-06-01 |
| 2012-05-31 | $22.51M | -1.4% | 2014-07-30, From 2011-06-01 |
| 2011-05-31 | $22.84M | +30.4% | 2013-07-30, From 2010-06-01 |
| 2010-05-31 | $17.52M | n/a | 2012-07-30, From 2009-06-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Neogen Corp (NEOG) | 2026-05-31 | -$7.90M | n/m |
| Myriad Genetics Inc (MYGN) | 2025-12-31 | -$365.90M | n/m |
| Lantheus Holdings, Inc. (LNTH) | 2025-12-31 | $233.56M | -25.2% |
| QuidelOrtho Corp (QDEL) | 2025-12-28 | -$1.13B | n/m |
| Idexx Laboratories Inc (IDXX) | 2025-12-31 | $1.06B | +19.3% |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | -$412.69M | n/m |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | -$17.26M | n/m |
| Immucell Corp (ICCC) | 2025-12-31 | -$1.04M | n/m |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | -$12.78M | n/m |
Compare NEOG, MYGN, LNTH, QDEL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗